First Time Loading...

ImmunoGen Inc
NASDAQ:IMGN

Watchlist Manager
ImmunoGen Inc Logo
ImmunoGen Inc
NASDAQ:IMGN
Watchlist
Price: 31.23 USD Market Closed
Updated: May 3, 2024
Section:
 

Wall Street
Price Targets

IMGN Price Targets Summary
ImmunoGen Inc

Wall Street analysts forecast IMGN stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMGN is 25.5 USD .

IMGN Lowest Forecast
Wall Street Target
Not Available
IMGN Average Forecast
Wall Street Target
25.5 USD
18% Downside
IMGN Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
25.5 USD
18% Downside
Highest
Price Target
Not Available

IMGN Last Price Targets
ImmunoGen Inc

The latest public price target was made on Sep 13, 2023 by Brian Cheng from J.P. Morgan , who expects IMGN stock to drop by 30% over the next 12 months. You can read more about this price target by viewing the article on Benzinga.

Analyst Price Target Date Article
Brian Cheng
J.P. Morgan
22 USD
Downside 30%
7 months ago
Sep 13, 2023
Ovarian Cancer Player ImmunoGen Can Potentially Be Attractive M&A Target: JP Morgan
Benzinga
Joseph Catanzaro
Piper Sandler
16 USD
Downside 49%
1 year ago
May 3, 2023
Piper Sandler Upgrades Immunogen Inc. (IMGN) to Overweight
StreetInsider
Brian Cheng
J.P. Morgan
Price Target 22 USD
Upside/Downside 30%
View Source
Joseph Catanzaro
Piper Sandler
Price Target 16 USD
Upside/Downside 49%
View Source
ImmunoGen Inc Competitors:
Price Targets
CRBU
Caribou Biosciences Inc
460% Upside
I
IMRX
Immuneering Corp
752% Upside
INBX
Inhibrx Inc
6% Upside
I
IVVD
Invivyd Inc
303% Upside
CRBU
Caribou Biosciences Inc
460% Upside
I
IMRX
Immuneering Corp
752% Upside
INBX
Inhibrx Inc
6% Upside
I
IVVD
Invivyd Inc
303% Upside
ZYME
Zymeworks Inc
70% Upside
300685
Amoy Diagnostics Co Ltd
30% Upside
I
TIL
Instil Bio Inc
152% Upside
PTCT
PTC Therapeutics Inc
14% Downside

Revenue
Forecast

Revenue Estimate
ImmunoGen Inc

For the last 9 years the compound annual growth rate for ImmunoGen Inc's revenue is 7%. The projected CAGR for the next 4 years is 75%.

7%
Past Growth
75%
Estimated Growth
Estimates Accuracy
10%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
ImmunoGen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
ImmunoGen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-53%
Average Miss
What are analyst estimates?

See Also

Summary
IMGN intrinsic value, competitors valuation, and company profile.
DCF Valuation
IMGN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IMGN stock valuation using valuation multiples.
Wall Street Estimates
IMGN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IMGN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMGN's stock price target?
Price Target
25.5 USD

According to Wall Street analysts, the average 1-year price target for IMGN is 25.5 USD .

What is ImmunoGen Inc's Revenue forecast?
Projected CAGR
75%

For the last 9 years the compound annual growth rate for ImmunoGen Inc's revenue is 7%. The projected CAGR for the next 4 years is 75%.

ALPHA SPREAD
Join more than 133,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.